Poolbeg Pharma Statistics

Total Valuation

Poolbeg Pharma has a market cap or net worth of GBP 23.25 million. The enterprise value is 13.19 million.

Market Cap	23.25M
Enterprise Value	13.19M

Important Dates

The next estimated earnings date is Monday, March 3, 2025.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Poolbeg Pharma has 500.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	500.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	21.23%
Owned by Institutions (%)	47.29%
Float	381.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.87
P/TBV Ratio	2.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.01
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.61

Current Ratio	19.61
Quick Ratio	18.49
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.18% and return on invested capital (ROIC) is -22.11%.

Return on Equity (ROE)	-30.18%
Return on Assets (ROA)	-21.33%
Return on Capital (ROIC)	-22.11%
Revenue Per Employee	n/a
Profits Per Employee	-291,867
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.35% in the last 52 weeks. The beta is 2.14, so Poolbeg Pharma's price volatility has been higher than the market average.

Beta (5Y)	2.14
52-Week Price Change	-45.35%
50-Day Moving Average	6.64
200-Day Moving Average	10.26
Relative Strength Index (RSI)	34.98
Average Volume (20 Days)	4,640,895

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-5.13M
Pretax Income	-4.98M
Net Income	-4.38M
EBITDA	-5.11M
EBIT	-5.13M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	10.06M
Total Debt	n/a
Net Cash	10.06M
Net Cash Per Share	0.02
Equity (Book Value)	12.45M
Book Value Per Share	0.02
Working Capital	10.44M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.36M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Poolbeg Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a